• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颅内动脉粥样硬化支架置入术的人口统计学特征及治疗结果:216例连续患者的回顾性病例系列研究

Demographic Characteristics and Treatment Outcomes of Intracranial Atherosclerosis Stenting: A Retrospective Case-Series of 216 Consecutive Patients.

作者信息

Sarshayev Marat, Turdaliyeva Botagoz, Tanbayeva Gulnur, Makhanbetkhan Shayakhmet, Mussabekov Maxat, Davletov Dimash, Maidan Aiman, Berdikhojayev Mynzhylky

机构信息

"Joint-Stock Company" Central Clinical Hospital, Almaty 050060, Kazakhstan.

Kazakhstan School of Public Health, Kazakhstan's Medical University, Almaty 050060, Kazakhstan.

出版信息

J Clin Med. 2024 Dec 28;14(1):125. doi: 10.3390/jcm14010125.

DOI:10.3390/jcm14010125
PMID:39797208
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11721944/
Abstract

Intracranial atherosclerosis (ICAS) is a major cause of ischemic stroke, disproportionately affecting populations with significant vascular risk factors. Although ICAS imposes a considerable health burden, research on this condition in Central Asia remains scarce, especially among the Kazakh population. This study analyzes demographic characteristics, treatment outcomes, and procedural challenges associated with ICAS in 216 patients treated at a single institution. This retrospective study included patients with ≥70% intracranial artery stenosis confirmed by imaging and presenting with ischemic symptoms. All patients underwent angioplasty and stenting with dual antiplatelet therapy (DAPT). Data collected included demographics, comorbidities, stenosis characteristics, procedural details, and outcomes assessed by the modified Rankin Scale (mRS). The median age was 63.5 years (IQR: 57-68.6), and 73.7% were male. Hypertension was the most common comorbidity (98%), followed by ischemic heart disease (58%) and diabetes mellitus (40.9%). Multi-location ICAS was significantly associated with patients over 75 years of age ( = 0.025). Additionally, obesity and stenosis severity greater than 70% showed trends toward significance, with -values of 0.064 and 0.079, respectively. Stenosis predominantly affected the internal carotid artery (54.5%) and vertebrobasilar system (31.6%). The average hospital stay was longer for posterior circulation stenosis (7.1 days) compared to anterior circulation (4.7 days). The periprocedural complication rate was 0.7%, with two deaths attributed to ischemic complications. At follow-up, four patients experienced worsening mRS scores (>2), particularly those with severe stenosis in the basilar artery and M1 segment. ICAS in the Kazakh population is strongly associated with hypertension and aging, with posterior circulation stenosis contributing disproportionately to worse outcomes. The low complication rates highlight the safety of modern endovascular techniques. However, further research is needed to optimize treatment strategies for severe and multi-location ICAS, particularly in Central Asian populations.

摘要

颅内动脉粥样硬化(ICAS)是缺血性中风的主要原因,对具有显著血管危险因素的人群影响尤为严重。尽管ICAS带来了相当大的健康负担,但中亚地区对这种疾病的研究仍然很少,尤其是在哈萨克族人群中。本研究分析了在单一机构接受治疗的216例ICAS患者的人口统计学特征、治疗结果和手术挑战。这项回顾性研究纳入了经影像学证实颅内动脉狭窄≥70%且有缺血症状的患者。所有患者均接受了血管成形术和支架置入术,并辅以双重抗血小板治疗(DAPT)。收集的数据包括人口统计学、合并症、狭窄特征、手术细节以及通过改良Rankin量表(mRS)评估的结果。中位年龄为63.5岁(四分位间距:57 - 68.6岁),73.7%为男性。高血压是最常见的合并症(98%),其次是缺血性心脏病(58%)和糖尿病(40.9%)。多部位ICAS与75岁以上患者显著相关(P = 0.025)。此外,肥胖和狭窄严重程度大于70%呈现出显著趋势,P值分别为0.064和0.079。狭窄主要影响颈内动脉(54.5%)和椎基底系统(31.6%)。后循环狭窄患者的平均住院时间(7.1天)比前循环狭窄患者(4.7天)更长。围手术期并发症发生率为0.7%,有两例死亡归因于缺血性并发症。在随访中,四名患者的mRS评分恶化(>2),特别是那些基底动脉和M1段严重狭窄的患者。哈萨克族人群中的ICAS与高血压和老龄化密切相关,后循环狭窄对不良结局的影响尤为突出。低并发症发生率凸显了现代血管内技术的安全性。然而,需要进一步研究以优化针对严重和多部位ICAS的治疗策略,特别是在中亚人群中。

相似文献

1
Demographic Characteristics and Treatment Outcomes of Intracranial Atherosclerosis Stenting: A Retrospective Case-Series of 216 Consecutive Patients.颅内动脉粥样硬化支架置入术的人口统计学特征及治疗结果:216例连续患者的回顾性病例系列研究
J Clin Med. 2024 Dec 28;14(1):125. doi: 10.3390/jcm14010125.
2
Intracranial Atherosclerotic Stenosis.颅内动脉粥样硬化性狭窄
Cerebrovasc Dis Extra. 2025;15(1):62-67. doi: 10.1159/000543356. Epub 2025 Jan 2.
3
Direct angioplasty for acute ischemic stroke due to intracranial atherosclerotic stenosis-related large vessel occlusion.颅内动脉粥样硬化性狭窄相关大血管闭塞所致急性缺血性卒中的直接血管成形术
Interv Neuroradiol. 2020 Oct;26(5):602-607. doi: 10.1177/1591019920949674. Epub 2020 Aug 10.
4
Angioplasty and Stenting of Intracranial Arterial Stenosis in Perforator-Bearing Segments: A Comparison Between the Anterior and the Posterior Circulation.穿支动脉供血节段颅内动脉狭窄的血管成形术和支架置入术:前循环与后循环的比较
Front Neurol. 2018 Jul 9;9:533. doi: 10.3389/fneur.2018.00533. eCollection 2018.
5
Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective Phase I study.症状性颅内动脉粥样硬化的次最大血管成形术:一项前瞻性 I 期研究。
J Neurosurg. 2016 Oct;125(4):964-971. doi: 10.3171/2015.8.JNS15791. Epub 2016 Jan 8.
6
Concomitant Asymptomatic Intracranial Atherosclerotic Stenosis Increase the 30-Day Risk of Stroke in Patients Undergoing Symptomatic Intracranial Atherosclerotic Stenosis Stenting.合并无症状颅内动脉粥样硬化狭窄会增加有症状颅内动脉粥样硬化狭窄支架置入患者30天的卒中风险。
J Stroke Cerebrovasc Dis. 2018 Feb;27(2):479-485. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.032. Epub 2017 Oct 19.
7
Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.下肢外周动脉疾病的支架置入术:一项基于证据的分析。
Ont Health Technol Assess Ser. 2010;10(18):1-88. Epub 2010 Sep 1.
8
Long-term outcome and factors associated with restenosis after combination therapy of balloon angioplasty and stenting for symptomatic intracranial stenosis.症状性颅内狭窄球囊血管成形术和支架置入联合治疗后再狭窄的长期结果及相关因素。
BMC Neurol. 2022 Dec 13;22(1):477. doi: 10.1186/s12883-022-03009-1.
9
Endovascular treatment of symptomatic severe intracranial atherosclerotic stenosis with a novel intracranial dedicated drug-eluting stent: a more effective treatment approach.采用新型颅内专用药物洗脱支架对症状性重度颅内动脉粥样硬化狭窄进行血管内治疗:一种更有效的治疗方法。
Front Neurol. 2024 Feb 22;15:1304524. doi: 10.3389/fneur.2024.1304524. eCollection 2024.
10
Stenting for symptomatic intracranial arterial stenosis in China: 1-year outcome of a multicentre registry study.中国症状性颅内动脉狭窄血管内治疗:一项多中心注册研究的 1 年结果。
Stroke Vasc Neurol. 2018 May 7;3(3):176-184. doi: 10.1136/svn-2017-000137. eCollection 2018 Sep.

本文引用的文献

1
Establishment of an Atherosclerosis and Dyslipidemia Program in Kazakhstan.
Mayo Clin Proc. 2024 Nov;99(11):1698-1701. doi: 10.1016/j.mayocp.2024.05.023. Epub 2024 Oct 7.
2
Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球、区域和国家的卒中负担及其风险因素,1990-2021 年:2021 年全球疾病负担研究的系统分析。
Lancet Neurol. 2024 Oct;23(10):973-1003. doi: 10.1016/S1474-4422(24)00369-7.
3
Improving multidisciplinary hospital care for acute cerebral circulation disorders in Kazakhstan.改善哈萨克斯坦急性脑循环障碍的多学科医院护理。
Heliyon. 2023 Aug 1;9(8):e18435. doi: 10.1016/j.heliyon.2023.e18435. eCollection 2023 Aug.
4
Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis: The CASSISS Randomized Clinical Trial.支架置入联合药物治疗与单纯药物治疗对症状性颅内狭窄患者卒中和死亡风险的影响:CASSISS 随机临床试验。
JAMA. 2022 Aug 9;328(6):534-542. doi: 10.1001/jama.2022.12000.
5
Editor's Choice - European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease.编辑推荐——欧洲血管外科学会(ESVS)2023年动脉粥样硬化性颈动脉和椎动脉疾病管理临床实践指南
Eur J Vasc Endovasc Surg. 2023 Jan;65(1):7-111. doi: 10.1016/j.ejvs.2022.04.011. Epub 2022 May 20.
6
Endovascular Treatment of Large Vessel Occlusion Strokes Due to Intracranial Atherosclerotic Disease.颅内动脉粥样硬化性疾病所致大血管闭塞性卒中的血管内治疗
J Stroke. 2022 Jan;24(1):3-20. doi: 10.5853/jos.2021.01375. Epub 2022 Jan 31.
7
Intracranial Stenting; the Current Landscape.颅内支架置入术;当前形势
Neurointervention. 2021 Mar;16(1):2-5. doi: 10.5469/neuroint.2021.00087. Epub 2021 Feb 24.
8
Hyperglycemia, duration of diabetes, and intracranial atherosclerotic stenosis by magnetic resonance angiography: The ARIC-NCS study.高血糖、糖尿病病程和磁共振血管造影颅内动脉粥样硬化狭窄:ARIC-NCS 研究。
J Diabetes Complications. 2020 Sep;34(9):107605. doi: 10.1016/j.jdiacomp.2020.107605. Epub 2020 Apr 28.
9
The WOVEN trial: Wingspan One-year Vascular Events and Neurologic Outcomes.WOVEN 试验:Wingspan 一年血管事件和神经结局。
J Neurointerv Surg. 2021 Apr;13(4):307-310. doi: 10.1136/neurintsurg-2020-016208. Epub 2020 Jun 19.
10
WEAVE Trial: Final Results in 152 On-Label Patients.WEAVE 试验:152 名适应证患者的最终结果。
Stroke. 2019 Apr;50(4):889-894. doi: 10.1161/STROKEAHA.118.023996.